NCT01673802View on ClinicalTrials.gov

The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Cholangiocarcinoma
Interventions
DRUG

CT scan

Gadoxetate (Eovist) enhanced dual energy CT

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

Society of Abdominal Radiology

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT01673802 - The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma | Biotech Hunter | Biotech Hunter